Cite

    Ebrahimi, A., Raichlen, J. S., Pointon, A., Gottfridsson, C., Munley, J., Hockings, P., Cartwright, J., Buss, N., Wikström, J., Gan, L., Whittaker, A., Khalil, A., George, R. T., Garkaviy, P., & Brott, D. (2020). drug-induced myocardial dysfunction – recommendations for assessment in clinical and pre-clinical studies. Expert opinion on drug safety, 19(3), 281–294. http://access.bl.uk/ark:/81055/vdc_100105295582.0x000028